![Kitty Yale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kitty Yale formerly worked at Gilead Sciences, Inc., as Vice President-Clinical Operations from 2001 to 2018, Roche Global Development, as Senior Clinical Research & Operations, and Akero Therapeutics, Inc., as Chief Development Officer from 2018 to 2025.
Ms. Yale received her undergraduate degree from Glasgow Caledonian University.
Anciens postes connus de Kitty Yale
| Sociétés | Poste | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 09/12/2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2018 |
Roche Global Development | Corporate Officer/Principal | - |
Formation de Kitty Yale
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Glasgow Caledonian University
 Glasgow Caledonian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Global Development | |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
